You have 9 free searches left this month | for more free features.

Anti-Tumor

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Malignant Solid Tumor, RAS Mutation, Lung Cancer Trial in United States (RSC-1255 Dose Escalation, RSC-1255 Dose

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +5 more
  • RSC-1255 Dose Escalation
  • RSC-1255 Dose Expansion
  • Los Angeles, California
  • +5 more
Oct 24, 2022

Anesthesia Trial (PENG Block, Control Group)

Not yet recruiting
  • Anesthesia
  • PENG Block
  • Control Group
  • (no location specified)
Jun 15, 2023

HIV, AIDS, Immunologic Deficiency Syndrome, Acquired Trial in Boston (Ad26.Mos4.HIV, MVA-BN-HIV, PGT121)

Recruiting
  • HIV
  • +4 more
  • Ad26.Mos4.HIV
  • +4 more
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Apr 18, 2022

Uveitis Trial in Worldwide (Adalimumab (ADA), Conventional immunosuppression (CON))

Recruiting
  • Uveitis
  • Adalimumab (ADA)
  • Conventional immunosuppression (CON)
  • Los Angeles, California
  • +27 more
Jun 16, 2022

Cancer Trial in Shenzhen (No experimental interventions 1. Observation; 2. Anticancer treatments, including surgery, systemic

Recruiting
  • Cancer
  • No experimental interventions 1. Observation; 2. Anticancer treatments, including surgery, systemic therapy, radiotherapy, Chinese traditional medicine, or palliative/supportive care.
  • Shenzhen, Guangdong, China
    UHongKongShenzhen
Sep 20, 2021

Prostate Cancer, Prostate Adenocarcinoma Trial in Miami (Lattice Extreme Ablative Dose Radiation Therapy, Standard IMRT)

Completed
  • Prostate Cancer
  • Prostate Adenocarcinoma
  • Lattice Extreme Ablative Dose Radiation Therapy
  • Standard IMRT
  • Miami, Florida
    University of Miami
Jul 11, 2021

Colorectal Cancer, Non Small Cell Lung Cancer Trial in France (Liquid biopsy)

Recruiting
  • Colorectal Cancer
  • Non Small Cell Lung Cancer
  • Liquid biopsy
  • Bayonne, France
  • +5 more
Feb 1, 2022

Acute Myeloid Leukemia Trial in Wuxi (Anti-CD33/CLL1 CAR-NK Cells)

Recruiting
  • Acute Myeloid Leukemia
  • Anti-CD33/CLL1 CAR-NK Cells
  • Wuxi, Jiangsu, China
    Wuxi People's Hospital
Jan 18, 2022

Metastatic Urothelial Carcinoma Trial (Pembrolizumab (200mg), Pembrolizumab (400mg), Monitoring)

Not yet recruiting
  • Metastatic Urothelial Carcinoma
  • Pembrolizumab (200mg)
  • +2 more
  • (no location specified)
Sep 18, 2023

Leukemia Trial in Bronx (deglycosylated ricin A chain-conjugated anti-CD19/anti-CD22 immunotoxins)

Completed
  • Leukemia
  • deglycosylated ricin A chain-conjugated anti-CD19/anti-CD22 immunotoxins
  • Bronx, New York
    Albert Einstein Cancer Center at Albert Einstein College of Medi
Apr 9, 2021

Pancreatic Adenocarcinoma, Pancreas Cancer Trial in Roma, Rome (EUS-guided laser ablation)

Terminated
  • Pancreatic Adenocarcinoma
  • Pancreas Cancer
  • EUS-guided laser ablation
  • Roma, RM, Italy
  • +1 more
Feb 10, 2022

Solid Tumors Trial in Worldwide (INCB0123667)

Recruiting
  • Solid Tumors
  • Duarte, California
  • +34 more
Dec 12, 2022

Medical Marijuana in Pediatric Central Nervous System Tumor

Active, not recruiting
  • Central Nervous System Tumor
  • +2 more
    • Aurora, Colorado
      Chilsdren's Hospital Colorado
    Oct 14, 2022

    Brain Tumor Trial in Phoenix (MRI)

    Recruiting
    • Brain Tumor
    • MRI
    • Phoenix, Arizona
      St. Joseph's Hospital and Medical Center
    Sep 20, 2021

    Desmoplastic Melanoma Trial in United States (Pembrolizumab, Therapeutic Conventional Surgery)

    Active, not recruiting
    • Desmoplastic Melanoma
    • Pembrolizumab
    • Therapeutic Conventional Surgery
    • Fairbanks, Alaska
    • +282 more
    Jun 28, 2022

    Bladder Tumor Trial in Istanbul (En Bloc Resection, Conventional Transurethral Resection Bladder Tumor (Mono/Bipolar))

    Recruiting
    • Bladder Neoplasm
    • En Bloc Resection
    • Conventional Transurethral Resection Bladder Tumor (Mono/Bipolar)
    • Istanbul, Bagcilar, Turkey
    • +1 more
    Apr 11, 2022

    Observational Study of Anti-Reflux Surgery

    Completed
    • GERD
    • +2 more
      • Vienna, Austria
      • +20 more
      May 13, 2021

      Solid Tumors and Hematologic Malignancy Trial in Australia (INCSHR01210 injection)

      Completed
      • Solid Tumors and Hematologic Malignancy
      • INCSHR01210 injection
      • Heidelberg, Victoria, Australia
      • +4 more
      Sep 26, 2019

      Malignant Peripheral Nerve Sheath Tumor Development in

      Active, not recruiting
      • Neurofibromatosis 1
      • Peripheral Nerve Neoplasms, Malignant
        • Bethesda, Maryland
          National Cancer Institute (NCI)
        Jul 6, 2022

        Medullary Thyroid Carcinoma, Multiple Endocrine Neoplasia Type 2A, Multiple Endocrine Neoplasia Type 2B Trial run by the NCI

        Completed
        • Medullary Thyroid Carcinoma
        • +2 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Dec 1, 2020

        Head and Neck Squamous Cell Cancer Trial in Philadelphia (INO-3112, CELLECTRA™-5P)

        Completed
        • Head and Neck Squamous Cell Cancer
        • INO-3112
        • CELLECTRA™-5P
        • Philadelphia, Pennsylvania
          University of Pennsylvania
        Jan 4, 2021

        Gastro-enteropancreatic Neuroendocrine Tumor Trial (Pasireotide, Diazoxide)

        Withdrawn
        • Gastro-enteropancreatic Neuroendocrine Tumor
        • (no location specified)
        Feb 17, 2022

        Recurrent Bladder Urothelial Carcinoma, Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7, Stage 0is Bladder Urothelial

        Active, not recruiting
        • Recurrent Bladder Urothelial Carcinoma
        • +3 more
        • Daphne, Alabama
        • +271 more
        Jul 20, 2022

        Epidermoid Carcinoma, Anus Trial in France (radiochemo, Panitumumab)

        Completed
        • Epidermoid Carcinoma
        • Anus
        • Bordeaux, France
        • +14 more
        Mar 23, 2022